Considering (1.) Doogan's background & new position of more power, (2.) Private Investors now more in charge of the company's direction, and (3.) The relatively new emphasis and US headquarter location; Amarin is being groomed to be eventually purchased by Pfizer.

Dr. Doogan joined Amarin in April 2007. Most recently, Dr. Doogan was Senior Vice President and Head of Worldwide Development at Pfizer Global Research & Development. In recent years, he held a number of senior positions in Pfizer in the US and the UK. Dr. Doogan joined Pfizer in 1982, where he led the Zoloft clinical development program. He held positions in the UK and in Japan, where he was initially Medical Director and later head of the company’s development organization.